Outcome Measures for Adult Becker Muscular Dystrophy Progression

Outcome Measures for Adult Becker Muscular Dystrophy Progression

This article is an excerpt from a natural history study published in Neurology in 2025, focusing on the sensitivity of clinical outcome measures in assessing adult patients with Becker Muscular Dystrophy (BMD) over a three-year period. Researchers aimed to identify which functional tests, such as the Rise From Floor velocity (RFFv) and the North Star Ambulatory Assessment (NSAA), were most responsive to the disease's slow and variable progression for use in clinical trials. The study concluded that RFFv was the only measure with high responsiveness across the entire cohort at three years, although selecting a subgroup based on phenotype (NSAA scores 10–32) significantly improved the sensitivity of RFFv, NSAA, and 4-stair climb velocity earlier in the follow-up. Furthermore, the analysis suggested that genotype selection did not significantly enhance responsiveness, and the decline in cardiac function occurred independently of skeletal muscle function. Overall, the findings recommend the use of NSAA in clinical trials for ambulant BMD patients due to its broad feasibility and consistent decline, especially when patients are selected based on baseline NSAA scores.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(226)

Extended Version - Examination and Localization of Eye Movement Disorders

Extended Version - Examination and Localization of Eye Movement Disorders

This epiode is an extended version of the recently published episode on the examination and localization of eye movement disorders. The orginal paper details a comprehensive clinical framework for the...

27 Syys 52min

Guidance for Applying the 2024 McDonald Criteria for MS Diagnosis

Guidance for Applying the 2024 McDonald Criteria for MS Diagnosis

This episode is a comprehensive review of a peper exploring the 2024 McDonald criteria, which represent a significant update to the global standards for diagnosing multiple sclerosis (MS). These revis...

27 Syys 45min

Anti-Amyloid Antibodies for Alzheimer’s Disease: Efficacy and Safety

Anti-Amyloid Antibodies for Alzheimer’s Disease: Efficacy and Safety

This umbrella review evaluates the clinical efficacy and safety of two recently approved anti-amyloid antibodies, lecanemab and donanemab, for treating early-stage Alzheimer’s disease. By synthesizing...

20 Syys 17min

Examination and Localization of Eye Movement Disorders

Examination and Localization of Eye Movement Disorders

This paper provides a comprehensive clinical framework for the examination and localization of eye movement disorders, emphasizing that the systematic bedside assessment serves as the primary tool for...

20 Syys 24min

 Liquid Biopsy: Current Applications and Future Direction

Liquid Biopsy: Current Applications and Future Direction

This comprehensive review examines the evolution and clinical potential of liquid biopsy, a non-invasive diagnostic method that analyzes biomarkers within bodily fluids. The text classifies primary bi...

13 Syys 17min

Palasma Exchange in Autoimmune Neurological Diseases

Palasma Exchange in Autoimmune Neurological Diseases

This systematic review and meta-analysis evaluates the effectiveness and safety of therapeutic plasma exchange (TPE) for treating autoimmune neurological diseases (ANDs). By analyzing 38 studies invol...

13 Syys 17min

 Parsonage-Turner Syndrome: A Comprehensive Clinical Review

Parsonage-Turner Syndrome: A Comprehensive Clinical Review

Parsonage-Turner syndrome, also known as neuralgic amyotrophy, is a frequently misdiagnosed peripheral nerve disorder characterized by sudden, intense shoulder pain followed by muscle weakness and atr...

13 Syys 22min

Neurological Involvement in Merkel Cell Carcinoma

Neurological Involvement in Merkel Cell Carcinoma

This clinical review examines the neurological complications associated with Merkel cell carcinoma (MCC), distinguishing between immune-mediated paraneoplastic syndromes and direct metastatic involvem...

7 Syys 11min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
aamukahvilla
psykopodiaa-podcast
tiedenaiset-podcast
vakeva-elama-viisaampi-mieli-vahvempi-keho
meditaatiot-suomeksi
rss-pitaisko-erota
rss-hereilla
rss-pt-paahtio
paritellen
voi-hyvin-meditaatiot-2
terapiassa
rss-kuumilla-aalloilla
katilon-kahvitunti
paaasia-podcast
rss-uplevel-by-sonja-hannus
selviytyjat-tarinoita-elamasta
rss-mutkalla
rss-onnistunut-laihdutus
rss-rentoudu-podcast-rentoutumiseen-hanna-viljanmaa